Parkinson's disease
Conditions
Interventions
treatment group:Oral Danxing antifibrillation granule + conventional parkinsonism western medicine treatment
control group:conventional parkinsonism western medicine treatment
Sponsors
Affiliated Hospital of Shaanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for PD in Western medicine; (2) Meet the diagnostic criteria of fibrillation syndrome and phlegm-stasis interjunction type; (3) Age 40-80 years old, regardless of gender; (4) Hoehn&Yahr grade =3; (5) Informed and consented to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Patients with serious diseases or organ failure; (2) Psychiatric or extracranial injuries; (3) a history of drug abuse or alcoholism; (4) the subject is allergic to the test drug; (5) Have participated in other clinical drug trials within 3 months; (6) Unable or unwilling to take the test drug because of swallowing dysfunction; (7) Pregnant women and lactating patients; (8) Patients who had undergone DBS surgery;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motion section of the Parkinson's Disease Uniform Scale(UPDRS-III); | — |
Secondary
| Measure | Time frame |
|---|---|
| Parkinson's Quality of Life questionnaire;TCM syndrome score scale for Parkinson's disease;Montreal Cognitive Assessment Scale; | — |
Countries
China
Contacts
Public Contactyanyongmei
Affiliated Hospital of Shaanxi University of Chinese Medicine
Outcome results
None listed